Literature DB >> 11108333

Acute reversible cardiomyopathy and thromboembolism after cisplatin and 5-fluorouracil chemotherapy--a case report.

K M Cheriparambil1, H Vasireddy, A Kuruvilla, B Gambarin, M Makan, B I Saul.   

Abstract

Acute development of cardiomyopathy and occlusive thromboembolic events following cisplatin and 5-fluorouracil (5-FU) is rare but frequently lethal. The authors report the successful management of such an event in a 52-year-old man with squamous cell carcinoma of the soft palate. The possible pathophysiological mechanisms are discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11108333     DOI: 10.1177/000331970005101011

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  5 in total

Review 1.  Chemotherapeutic Agents and the Risk of Ischemia and Arterial Thrombosis.

Authors:  Saamir A Hassan; Nicolas Palaskas; Peter Kim; Cezar Iliescu; Juan Lopez-Mattei; Elie Mouhayar; Rohit Mougdil; Kara Thompson; Jose Banchs; Syed Wamique Yusuf
Journal:  Curr Atheroscler Rep       Date:  2018-02-08       Impact factor: 5.113

2.  Chemotherapy-induced Takotsubo cardiomyopathy, a case report and review of the literature.

Authors:  Matteo Coen; Fabio Rigamonti; Arnaud Roth; Thibaud Koessler
Journal:  BMC Cancer       Date:  2017-06-02       Impact factor: 4.430

3.  Evaluating the protective potency of Acacia hydaspica R. Parker on histological and biochemical changes induced by Cisplatin in the cardiac tissue of rats.

Authors:  Tayyaba Afsar; Suhail Razak; Ali Almajwal; Maria Shabbir; Muhammad Rashid Khan
Journal:  BMC Complement Altern Med       Date:  2019-07-23       Impact factor: 3.659

Review 4.  Takotsubo cardiomyopathy in cancer patients.

Authors:  Aakash Desai; Arish Noor; Saurabh Joshi; Agnes S Kim
Journal:  Cardiooncology       Date:  2019-07-01

Review 5.  Cisplatin-induced cardiotoxicity with midrange ejection fraction: A case report and review of the literature.

Authors:  Yang Hu; Bin Sun; Bin Zhao; Dan Mei; Qing Gu; Zhuang Tian
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.